The interactions between DNA nanostructures and cells: A critical overview from a cell biology perspective
Source abstract
Abstract
DNA nanotechnology has yielded remarkable advances in composite materials with diverse applications in biomedicine. The specificity and predictability of building 3D structures at the nanometer scale make DNA nanotechnology a promising tool for uses in biosensing, drug delivery, cell modulation, and bioimaging. However, for successful translation of DNA nanostructures to real-world applications, it is crucial to understand how they interact with living cells, and the consequences of such interactions. In this review, we summarize the current state of knowledge on the interactions of DNA nanostructures with cells. We identify key challenges, from a cell biology perspective, that influence progress towards the clinical translation of DNA nanostructures. We close by providing an outlook on what questions must be addressed to accelerate the clinical translation of DNA nanostructures. STATEMENT OF SIGNIFICANCE: Self-assembled DNA nanostructures (DNs) offers unique opportunities to overcome persistent challenges in the nanobiotechnology field. However, the interactions between engineered DNs and living cells are still not well defined. Critical systematization of current cellular models and biological responses triggered by DNs is a crucial foundation for the successful clinical translation of DNA nanostructures. Moreover, such an analysis will identify the pitfalls and challenges that are present in the field, and provide a basis for overcoming those challenges.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Anodic Oxide Films and Nanostructures
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Current understanding of biological identity at the nanoscale and future prospects10.1038/s41565-021-00860-0 ↗
2. Multifunctional biomolecule nanostructures for cancer therapy10.1038/s41578-021-00315-x ↗
3. The success of nanomedicine10.1016/j.nantod.2020.100853 ↗
4. Metal nanoparticles in ionic liquids: synthesis and catalytic applications10.1016/j.ccr.2021.213982 ↗
5. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
6. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
7. Tracking immune cells in vivo using magnetic resonance imaging10.1038/nri3531 ↗
8. Diverse applications of nanomedicine10.1021/acsnano.6b06040 ↗
9. Drug delivery systems: entering the mainstream10.1126/science.1095833 ↗
10. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
11. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
12. Remote actuation of apoptosis in liver cancer cells via magneto-mechanical modulation of iron oxide nanoparticles10.3390/cancers11121873 ↗
13. Nanoparticles in the clinic: an update10.1002/btm2.10143 ↗
14. New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy10.1016/j.drup.2016.10.003 ↗
15. Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions10.1021/acsnano.6b08244 ↗
16. What went wrong with anticancer nanomedicine design and how to make it right10.1021/acsnano.9b09713 ↗
17. Nanomedicine and the complement paradigm10.1016/j.nano.2013.02.011 ↗
18. Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach10.1021/acsnano.9b08142 ↗
19. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
20. The beginning of the end of the nanomedicine hype10.1016/j.jconrel.2019.05.044 ↗
21. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: a road from failure to success in clinical applications10.1016/j.jconrel.2020.08.036 ↗
22. Immunological principles guiding the rational design of particles for vaccine delivery10.1021/acsnano.6b07343 ↗
23. The entry of nanoparticles into solid tumours10.1038/s41563-019-0566-2 ↗
24. Dey · Nature Rev. Methods Primers · 2021 · 1 · 1310.1038/s43586-020-00009-8 ↗
25. Recent advances in shape-controlled synthesis of noble metal nanoparticles by radiolysis route10.1186/s11671-016-1500-z ↗
26. Controlling size, morphology, and surface composition of AgAu nanodendrites in 15s for improved environmental catalysis under low metal loadings10.1021/acsami.5b08725 ↗
27. Dynamic DNA nanostructures in biomedicine: beauty, utility and limits10.1016/j.jconrel.2019.10.003 ↗
28. Programmable, self-assembled DNA nanodevices for cellular programming and tissue engineering10.1039/D1NR04475C ↗
29. Hybrid nanostructures from the self-assembly of proteins and DNA10.1016/j.chempr.2020.01.012 ↗
30. Emerging applications at the interface of DNA nanotechnology and cellular membranes: perspectives from biology, engineering, and physics10.1063/5.0027022 ↗
31. Structural DNA nanotechnology: artificial nanostructures for biomedical research10.1146/annurev-bioeng-062117-120904 ↗
32. Functionalizing DNA nanostructures for therapeutic applications10.1002/wnan.1729 ↗
33. Scaffolds for creating higher order structures10.1021/acs.chemrev.6b00825 ↗
34. Challenges and perspectives of DNA nanostructures in biomedicine10.1002/anie.201916390 ↗
35. The single-step synthesis of a DNA tetrahedron10.1039/b402293a ↗
36. DNA rendering of polyhedral meshes at the nanoscale10.1038/nature14586 ↗
37. Complex wireframe DNA nanostructures from simple building blocks10.1038/s41467-019-08647-7 ↗
38. Folding DNA to create nanoscale shapes and patterns10.1038/nature04586 ↗
39. DNA origami with complex curvatures in three-dimensional space10.1126/science.1202998 ↗
40. Self-assembly of DNA into nanoscale three-dimensional shapes10.1038/nature08016 ↗
41. Three-dimensional structures self-assembled from DNA bricks10.1126/science.1227268 ↗
42. DNA functional materials assembled from branched DNA: design, synthesis, and applications10.1021/acs.chemrev.0c00294 ↗
43. Paranemic crossover DNA: there and back again10.1021/acs.chemrev.8b00207 ↗
44. Self-assembly of a nanoscale DNA box with a controllable lid10.1038/nature07971 ↗
45. DNA-based delivery vehicles: pH-controlled disassembly and cargo release10.1039/c2cc37471d ↗
46. Dynamic DNA devices and assemblies formed by shape-complementary, non-base pairing 3D components10.1126/science.aaa5372 ↗
47. Complex multicomponent patterns rendered on a 3D DNA-barrel pegboard10.1038/s41467-020-18910-x ↗
48. Supramolecular self-assembled DNA nanosystem for synergistic chemical and gene regulations on cancer cells10.1002/anie.202111900 ↗
49. An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy10.1039/C5TB00956A ↗
50. Nanotoxicity: an interplay of oxidative stress, inflammation and cell death10.3390/nano5031163 ↗
51. Self-assembly of DNA into nanoscale three-dimensional shapes10.1038/nature08016 ↗
52. A self-assembled rhombohedral DNA crystal scaffold with tunable cavity sizes and high-resolution structural detail10.1002/anie.202005505 ↗
53. Mechanism matters10.1038/nm0410-347 ↗
54. If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine10.1084/jem.20071737 ↗
55. Target identification and mechanism of action in chemical biology and drug discovery10.1038/nchembio.1199 ↗
56. Elucidating mechanisms of drug-induced toxicity10.1038/nrd1720 ↗
57. Critical analysis of non-thermal plasma-driven modulation of immune cells from clinical perspective10.3390/ijms21176226 ↗
58. A decade of the protein corona10.1021/acsnano.7b08008 ↗
59. Protein corona formation around nanoparticles - from the past to the future10.1039/C3MH00106G ↗
60. The crown and the scepter: roles of the protein corona in nanomedicine10.1002/adma.201805740 ↗
61. Nuclease resistance of DNA nanostructures10.1038/s41570-021-00251-y ↗
62. Towards understanding of nanoparticle-protein corona10.1007/s00204-015-1458-0 ↗
63. Understanding the nanoparticle-protein corona complexes using computational and experimental methods10.1016/j.biocel.2016.02.008 ↗
64. Understanding biophysicochemical interactions at the nano-bio interface10.1038/nmat2442 ↗
65. Nanoparticle core stability and surface functionalization drive the mTOR signaling pathway in hepatocellular cell lines10.1038/s41598-017-16447-6 ↗
66. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface10.1038/nnano.2012.237 ↗
67. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine10.2217/nnm.15.6 ↗
68. Protein coating of DNA nanostructures for enhanced stability and immunocompatibility10.1002/adhm.201700692 ↗
69. Engineered diblock polypeptides improve DNA and gold solubility during molecular assembly10.1021/acsnano.6b07291 ↗
70. Precise coating of a wide range of DNA templates by a protein polymer with a DNA binding domain10.1021/acsnano.6b05938 ↗
71. Oligolysine-based coating protects DNA nanostructures from low-salt denaturation and nuclease degradation10.1038/ncomms15654 ↗
72. Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals10.1016/j.addr.2020.07.024 ↗
73. Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions10.1021/acsnano.9b03942 ↗
74. Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review10.1080/14686996.2019.1590126 ↗
75. The beauty and utility of DNA origami10.1016/j.chempr.2017.02.009 ↗
76. Protein corona inhibits endosomal escape of functionalized DNA nanostructures in living cells10.1021/acsami.1c14401 ↗
77. Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo10.1021/jacs.5b05694 ↗
78. Lipid signalling in disease10.1038/nrm2335 ↗
79. Cell-signalling dynamics in time and space10.1038/nrm1838 ↗
80. Getting across the cell membrane: an overview for small molecules, peptides, and proteins10.1007/978-1-4939-2272-7_3 ↗
81. Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages10.1021/nn203596e ↗
82. DNA cage delivery to mammalian cells10.1021/nn2005574 ↗
83. On the design of precision nanomedicines10.1126/sciadv.aat0919 ↗
84. Pointing in the right direction: controlling the orientation of proteins on nanoparticles improves targeting efficiency10.1021/acs.nanolett.8b04916 ↗
85. Engineering the orientation, density, and flexibility of single-domain antibodies on nanoparticles to improve cell targeting10.1021/acsami.9b20993 ↗
86. Targeting cancer cells: controlling the binding and internalization of antibody-functionalized capsules10.1021/nn3010476 ↗
87. Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies10.1038/ncomms13818 ↗
88. Ligand density and nanoparticle clustering cooperate in the multivalent amplification of epidermal growth factor receptor activation10.1021/acsnano.8b06141 ↗
89. Shape-dependent cellular processing of polyelectrolyte capsules10.1021/nn3046117 ↗
90. Shape and orientation matter for the cellular uptake of nonspherical particles10.1021/nl403949h ↗
91. Engineered nanoparticles interacting with cells: size matters10.1186/1477-3155-12-5 ↗
92. Particle shape enhances specificity of antibody-displaying nanoparticles10.1073/pnas.1216893110 ↗
93. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells10.1021/nl052396o ↗
94. Spatial control of membrane receptor function using ligand nanocalipers10.1038/nmeth.3025 ↗
95. Designer DNA architecture offers precise and multivalent spatial pattern-recognition for viral sensing and inhibition10.1038/s41557-019-0369-8 ↗
96. Determinants of ligand-functionalized DNA nanostructure-cell interactions10.1021/jacs.1c02298 ↗
97. A primer to scaffolded DNA origami10.1038/nmeth.1570 ↗
98. Rapid folding of DNA into nanoscale shapes at constant temperature10.1126/science.1229919 ↗
99. Spatial organization-dependent EphA2 transcriptional responses revealed by ligand nanocalipers10.1093/nar/gkaa274 ↗
100. Role of nanoscale antigen organization on B-cell activation probed using DNA origami10.1038/s41565-020-0719-0 ↗